Literature DB >> 7438574

Use of graded exercise testing in assessing the hypertensive patient.

M W Millar-Craig, V Balasubramanian, S Mann, E B Raftery.   

Abstract

Twenty-five patients with suspected hypertension were studied using the "Oxford" continuous intra-arterial blood pressure recording technique. Each patient carried out graded exercise on a bicycle ergometer, using a standard protocol, and then underwent a fully ambulatory 24-h outpatient blood pressure recording. Using computer analysis, ambulatory blood pressure in each patient was characterised by measuring the mean daytime systolic and diastolic pressures. Exercise was found to be associated with a characteristic increase in systolic and diastolic blood pressure. Submaximal and maximal exercise blood pressures were shown to correlate strongly with ambulatory blood pressure. A much weaker correlation was found between clinic and ambulatory blood pressure. These findings suggest that the blood pressure response to exercise may be a better indicator of elevated blood pressure than a causal clinic blood pressure in individual borderline subjects.

Entities:  

Mesh:

Year:  1980        PMID: 7438574     DOI: 10.1002/clc.4960030203

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  4 in total

1.  Exercise testing in assessment of hypertension.

Authors:  B Leibel; I Kobrin; D Ben-Ishay
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-27

2.  Once daily nisoldipine in hypertension: cuff and ambulatory intra-arterial blood pressure.

Authors:  G Brigden; M Heber; M Caruana; A Lahiri; E B Raftery
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Effects of chronic beta-blockade on intra-arterial blood pressure during motor car driving.

Authors:  M W Millar-Craig; S Mann; V Balasubramanian; P Cashman; E B Raftery
Journal:  Br Heart J       Date:  1981-06

4.  Role of exercise treadmill in diagnosing hypertension.

Authors:  F Fan; R A Wright
Journal:  J Natl Med Assoc       Date:  1985-12       Impact factor: 1.798

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.